Q32 Bio Inc risk profile
22 Normal where most of the sector sits
Measured 1 September 2026 from QTTB's filed statements. Recomputed nightly.
22 (Normal), driven by Cash conversion at 72, over 4 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 64 | Stretched | Volatile | One-year price volatility — 172.7% |
| Operating pressure | Reads cost_of_revenue, operating_expense, operating_income and revenue. No reading is stored for this company. | |||
| Cash conversion | 72 | Stretched | Stable | Cash conversion — -1.13x |
| Leverage and coverage | 0 | Contained | Easing | Current ratio — 4.85x |
| Competitive position | 8 | Contained | Stable | R&D-intensity gap against peers — +3.5 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.